Dr. Reddy’s Laboratories Secures U.S. FDA Approval for Rituximab Biosimilar
HYDERABAD, India, Aug. 1, 2026 Dr. Reddy’s Laboratories Ltd. announced that the U.S. Food and Drug Administration (FDA) has...
U.S. FDA
Advertisement
Tonix Pharmaceuticals Receives FDA Alignment for TNX-4800 Phase 2 Trial
BERKELEY HEIGHTS, N.J., Aug. 3, 2026 Tonix Pharmaceuticals Holding Corp. announced that it has received official Type C meeting...
Lupin Boosts U.S. Generics Business with FDA Approval
MUMBAI, India, and NAPLES, Fla., July 28, 2026 Lupin Limited has received U.S. Food and Drug Administration (FDA) approval...
Par Health Launchs First FDA-Approved Generic Janumet® XR in U.S.
ST. LOUIS – July 24, 2026 Par Health, Inc. has announced the U.S. launch of its generic version of...
Invivyd Receives FDA EUA Termination Notice for PEMGARDA
NEW HAVEN, Conn., July 6, 2026 Invivyd announced that the U.S. Food and Drug Administration (FDA) has issued a...
Advertisements
Lupin Receives U.S. FDA Tentative Approval for Enzalutamide Tablets
MUMBAI, India & NAPLES, Fla., June 26, 2026 Lupin Limited announced that it has received tentative approval from the...
Datasea Advances FDA Compliance for Acoustic BCI Device
BEIJING, China, June 12, 2026 Datasea Intelligent Technology Ltd. (NASDAQ: DTSS) has announced a significant step forward in its...
Lupin and Natco Win U.S. FDA Approval for Eribulin Injection
MUMBAI, India & NAPLES, Florida, USA, June 3, 2026 Lupin Limited and its alliance partner Natco Pharma have announced...
Novartis wins FDA approval for first oral BTKi in chronic urticaria
EAST HANOVER, N.J., Sept. 30, 2025 – Novartis today announced that the U.S. Food and Drug Administration (FDA) has...
Advertisement
